At Last, the Chips are up at State Bioscience Firm
GenTel has product on market, expects others soon
Journal Sentinel, 10.16.07
When Alex Vodenlich came to GenTel BioSciences Inc. in February 2003, he assumed the company was well-positioned for swift growth.
Nearly five years later, many say that time has finally arrived.
The Madison maker of chips that help researchers test for proteins now has a revenue-producing chip on the market. In January, the company is planning to introduce another chip that tests for proteins broadly associated with cancer, said Vodenlich, GenTel's president and chief executive officer.